# Taxus Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/taxus-pharma

- Industry: Pharmaceuticals
- Headquarters: Wuxi, China
- Website: www.taxuspharm.com
- Latest round: Series B (Apr 29, 2022)
- Investors on record: 4

## About

Founded in 2004 and based in Wuxi, China, Taxus Pharma is a pharmaceutical company that provides antineoplastic drugs. In 2022, the company was listed on the National Equities Exchange and Quotations. Its stock code is 873858. In May 2023, it raised CNY 40 million in strategic investment from new investor Guolian Group and individual investors. Following the transaction, Guolian Group will hold 2.03% of a minority stake in the company. Taxus Pharma belongs to Hongdou Group.

The company's main products include calcium folate, paclitaxel injection and allopurinol, etc. Paclitaxel injection is used in the first-line and second-line treatment of ovarian cancer, breast cancer and non-small cell lung cancer (NSCLC).

## Funding rounds

- Series B, Apr 29, 2022 — Broad Resources, Guangzhou Tianhui Capital Management, Wuxi Xishan Venture Capital, Xinshang Investment

## Investors

- Broad Resources (https://capitalatlas.ai/funds/broad-resources) — Series B
- Guangzhou Tianhui Capital Management — Series B
- Wuxi Xishan Venture Capital — Series B
- Xinshang Investment (https://capitalatlas.ai/funds/xinshang-investment) — Series B